BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.
S Beurlet, N Omidvar, P Gorombei, P Kreif, C Le Pogam, N Setterblad, P de la Grange, C Leboeuf, A Janin, M E Noguera, F Hervatin, L Sarda-Mantel, M Konopleva, M Andreeff, A W Tu, A C Fan, D W Felsher, Anthony Whetton, M Pla, R WestP Fenaux, C Chomienne, R A Padua
Research output: Contribution to journal › Article › peer-review
265Downloads
(Pure)
Fingerprint
Dive into the research topics of 'BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.'. Together they form a unique fingerprint.